2-Chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridinium sulfate

2-Chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridinium sulfate
Trade Name
Orphan Indication Fragile X syndrome
USA Market Approval USA
USA Designation Date 2012-03-09 00:00:00
Sponsor Hoffmann-La Roche, Inc.;340 Kingsland Street;Nutley, NJ, 07110-1199